Subscribe to
our newsletters

Subscribe to our newsletters!

Subscribe to our newsletter and get the latest news from the Nordics straight to your inbox.

Search in Nordic Life Science Insight

-
June 17, 2019
Karolinska Institutet Innovations AB

Meet Chunde Li – Chundsell Medical

Meet Chundsell Medical's Chund Li

Meet Chunde Li – Chundsell Medical

Meet Chundsell Medical's Chund Li


He is behind a unique test to distinguish benign prostate cancer from
aggressive forms of the condition that require immediate treatment. Finding
the right contacts at the right time was key to the success of the project.

Chunde Li came to Karolinska Institutet as a guest researcher in 1993 from China. Initially, the plan had been to return home after getting his doctorate, or move on to the US. But in the end he stayed in Sweden and set up Chundsell Medical after having identified a method that distinguishes between aggressive and low risk prostate cancers and can therefor be a complement to screening.

“I’m driven by seeing my patients on a daily basis. I want to be able to give them the best choice among current treaments or even new effective treatments in the future”, says Li

If you want to read more about Chunde Li and Chundsell Medical you can find the entire interview in our booklet 20 Years of innovation @ Karolinska Institutet

Last updated:
June 17, 2019

Karolinska Institutet Innovations AB

KI Innovations is an incubator and a wholly owned subsidiary of Karolinska Institutets holding company. KI Innovations utilizes research findings in life science by evaluating and verifying projects with commercial potential as well as supporting business development to corporate or licensing.

Click here to read more about us!
Get in touch with us!
Visit us
Send us mail


He is behind a unique test to distinguish benign prostate cancer from
aggressive forms of the condition that require immediate treatment. Finding
the right contacts at the right time was key to the success of the project.

Chunde Li came to Karolinska Institutet as a guest researcher in 1993 from China. Initially, the plan had been to return home after getting his doctorate, or move on to the US. But in the end he stayed in Sweden and set up Chundsell Medical after having identified a method that distinguishes between aggressive and low risk prostate cancers and can therefor be a complement to screening.

“I’m driven by seeing my patients on a daily basis. I want to be able to give them the best choice among current treaments or even new effective treatments in the future”, says Li

If you want to read more about Chunde Li and Chundsell Medical you can find the entire interview in our booklet 20 Years of innovation @ Karolinska Institutet

Last updated:
June 17, 2019

Karolinska Institutet Innovations AB

KI Innovations is an incubator and a wholly owned subsidiary of Karolinska Institutets holding company. KI Innovations utilizes research findings in life science by evaluating and verifying projects with commercial potential as well as supporting business development to corporate or licensing.

Click here to read more about us!
Get in touch with us!
Visit us
Send us mail